methyl quinuclidine-4-carboxylate;hydrochloride, 250mg

2,3-Dicyanohydroquinone, 99.0%, 1g

Dabigatran ethyl ester, ��98.0%, 25mg

2-Chloropyrimidine-5-carbaldehyde, 95.0%, 1g

Copper(II) sulphate pentahydrate, min. 99.5%, pa, ACS, ISO, 2.5 kg, plastic packaging.

2,2,2-Tribromoacetic acid, 95.0%, 500g

2-[4-(2-Fluoro-benzyloxy)-phenyl]-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane, 98%, 10g

4-Bromo-1-(bromomethyl)-2-methylbenzene, 95.0%, 5g

tert-Butyl oxazol-5-ylcarbamate, 95.0%, 5g

S-methylthioacetate, 97%, 5g

6-Bromoimidazo[1,2-b]pyridazine, 95.0%, 10g

Methyl 2-bromo-4-fluoro-5-hydroxybenzoate, 97%, 1g

5-Fluoroindole-2-carboxylic acid, 98.0%, 5g